EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Duration of antibiotic treatment for respiratory tract infections in primary care

Carl Llor iD, Malene Plejdrup Hansen iD, Jesper Lykkegaard iD, Jonas Olsen iD, Bent Håkan Lindberg iD, Ingrid Keilegavlen Rebnord iD, Pia Touboul Lundgren iD, Pascale Bruno iD, Anna Kowalczyk iD, Christos Lionis iD, Ruta Radzeviciene iD, Lina Jaruseviciene iD und 3 weitere

JAC-Antimicrobial Resistance · 26.12.2024 · 7 (1)

DOI: 10.1093/jacamr/dlaf028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 25.02.2025. Verfasst von Carl Llor und 14 weiteren Autor:innen. Beteiligte Einrichtung: University Institute in Primary Care Research Jordi Gol, Barcelona, Spain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union’s Third Health Programme, European Commission and/or the Health and Digital Executive Agency.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The primary driver of antimicrobial resistance is excessive antibiotic use, posing a global threat to public health. Reducing individual exposure to antibiotics is a key to addressing the problem. This study aimed to assess the duration of antibiotic courses administered to patients with acute respiratory tract infections (RTIs) in primary care.

Methods

Consecutive patients presenting with RTI symptoms were prospectively included from general practices and out-of-hours services in France, Greece, Lithuania, Poland and Spain for two winter periods (February to April 2022 and 2023). Data were collected using a paper-based Audit Project Odense template, with clinicians recording patient age, gender, RTI diagnosis, type of antibiotic prescribed and treatment duration.

Results

A total of 196 doctors (133 in general practice and 63 in out-of-hours services) registered 11 270 cases, with 34.0% (3835) receiving antibiotics. The mean antibiotic course duration was 7.52 days (SD 2.11), which was significantly longer for pneumonia, COVID-19 infection and pharyngotonsillitis (8.01, 8.00 and 7.74 days, respectively), and lowest for predominantly viral infections, such as the common cold and flu infection, laryngitis and acute bronchitis (6.32, 6.48 and 6.98 days, respectively; P < 0.001). A total of 26.7% of the courses were prescribed for 10 days or longer.

Conclusions

Antibiotic courses for common RTIs are often prolonged, which does not align with current recommendations for course duration. Antibiotics should be avoided in cases of predominantly viral infections and most mixed infections; however, if deemed necessary, the courses should be substantially reduced to minimize unnecessary exposure.

Autor:innen und Institutionen

  • University Institute in Primary Care Research Jordi Gol, Barcelona, Spain.
  • CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Department of Public Health, Research Unit for General Practice, University of Southern Denmark, Campusvej, 55. DK-5230 Odense, Denmark.
  • Center for General Practice, Aalborg University, Aalborg, Denmark.
  • Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.
  • NORCE Norwegian Research Centre AS, Bergen, Norway.

ORCID-Profile: Carl Llor, Malene Plejdrup Hansen, Jesper Lykkegaard, Jonas Olsen, Bent Håkan Lindberg, Ingrid Keilegavlen Rebnord, Pia Touboul Lundgren, Pascale Bruno, Anna Kowalczyk, Christos Lionis, Ruta Radzeviciene, Lina Jaruseviciene, Lars Bjerrum, Ana García-Sangenís

Förderung

  • European Union’s Third Health Programme
  • European Commission and/or the Health and Digital Executive Agency

Zitieren

APA

Llor, C., Hansen, M. P., Lykkegaard, J., Olsen, J., Lindberg, B. H., Rebnord, I. K., Touboul Lundgren, P., Bruno, P., Kowalczyk, A., Lionis, C., Radzeviciene, R., Jaruseviciene, L., Bjerrum, L., García-Sangenís, A., & HAPPY PATIENT Study Group (2024). Duration of antibiotic treatment for respiratory tract infections in primary care. JAC-Antimicrobial Resistance, 7(1). https://doi.org/10.1093/jacamr/dlaf028

Vancouver

Llor C, Hansen MP, Lykkegaard J, Olsen J, Lindberg BH, Rebnord IK, et al. Duration of antibiotic treatment for respiratory tract infections in primary care. JAC-Antimicrobial Resistance. 2024;7(1). doi:10.1093/jacamr/dlaf028

BibTeX
@article{Llor2024,
  author = {Llor, Carl and Hansen, Malene Plejdrup and Lykkegaard, Jesper and Olsen, Jonas and Lindberg, Bent Håkan and Rebnord, Ingrid Keilegavlen and Touboul Lundgren, Pia and Bruno, Pascale and Kowalczyk, Anna and Lionis, Christos and Radzeviciene, Ruta and Jaruseviciene, Lina and Bjerrum, Lars and García-Sangenís, Ana and HAPPY PATIENT Study Group, HAPPY PATIENT Study Group},
  title = {Duration of antibiotic treatment for respiratory tract infections in primary care},
  journal = {JAC-Antimicrobial Resistance},
  year = {2024},
  volume = {7},
  number = {1},
  doi = {10.1093/jacamr/dlaf028}
}
Kostenlos starten →